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ABSTRACT 
Objective: In the present work, a rapid, precise and sensitive HPLC Method with UV detection (237 nm) for analysis of Nadifloxacin in Bulk was 
developed.  
Methods: Chromatography was performed with a mobile phase containing a mixture of 0.05 %v/v trifluoro acetic acid and acetonitrile (65:35 v/v) 
with flow rate 1.2 ml min-l
Result: The retention time was found to be 12.3 min. In the range of 0.03-5 ppm, the linearity of Nadifloxacin shows a correlation co-efficient of 
0.9997. Percentage recovery of the drug was found to be good (98-102%). Validation of the developed method was successful for precision, 
robustness, specificity and selectivity and ruggedness.  
. The proposed method was validated as per the standard guidelines.  
Conclusion: The developed HPLC method was found to be simple, sensitive, precise, accurate and reproducible and can be successfully used for the 
quantitative estimation of Nadifloxacin in bulk.  
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INTRODUCTION 
Nadifloxacin (Fig. 1) is a potent, broad-spectrum, quinolone agent 
approved for topical use in acne vulgaris and skin infections. As 
exposure of pathogenic and colonizing bacteria to antibiotics results 
in drug resistance, it is not desirable to use an important, broad-
spectrum antibiotic, which belongs to a class of agents widely used 
systemically to treat a wide variety of infections, as a topically 
applied preparation. On this basis, Nadifloxacin is not a good option 
for topical treatment of acne when other effective non-antibiotic 
treatments are available. Nadifloxacin has potential as a topical 
agent for short-term treatment of skin infections. The arginine salt 
of its (-)-(S)-isomer is being developed as a parenteral agent based 
quinoloneon its potency against methicillin and -resistant 
Staphylococcus aureus. Several methods for determination of 
beenhaveNadifloxacin developed including UV-VIS 
spectrophotometric method [1] HPTLC [2-3] and HPLC [4-5]. For 
routine analysis, a simple and cost effective analytical method is 
preferred. A simple and rapid assay procedure was developed using 
the sample preparation and mobile phase preparation as described 
in Ref. 5. The objective of present study was to develop a simple, 
precise, accurate and economic HPLC analytical method with better 
detection range for the estimation of S-Nadifloxacin in bulk drugs. 
The developed method was validated as per ICH guidelines. And 
suitable statistical tests were performed on validation data.  
 
Fig. 1: Structure of Nadifloxacin 
 
MATERIALS AND METHODS 
Instrument 
Specifications of HPLC instrument used are as follows. A gradient 
high pressure liquid chromatograph (Shimadzu, class lc-series), 
system controller SCL 10AVP, with LC-10 AT pump and a Hypersil C-
18 column (150 mm x 4.6 mm i. d., particle size 5 μm) was used. The 
HPLC system was equipped with the Shimadzu class VP-5.0 software 
(system-1). Another HPLC system was used with following 
configuration: Agilent 1200 series, instant pilot software Chemstation 
plus, with micro-vacuum degasser G1379B, binary pump G1312B, diode 
array detector SL G1315C, thermostated column compartment G1367C 
(system-2). UV/Vis spectrophotometer (Shimadzu), sonicator (Lab 
companion), balance (Mettler Toledo) and pH meter (Lab India) were 
used in the research. 
Chemicals and reagents 
All the chemicals used were either of A. R. Grade or HPLC grade. 
Acetonitrile (RANKEM, HPLC Grade), Tri-Fluro Acetic acid (MERCK, 
AR Grade), Ammonia Solution (RANKEM, AR Grade) and Water (Milli 
Q) were used in the research work. Nadifloxacin was obtained as a 
gift sample from Apollo Pharmaceuticals, Mumbai, India. 
Determination of wavelength 
Wavelength determination of Nadifloxacin was carried out by the 
procedure as suggested by Devhadrao et al [6]. Solution of 
Nadifloxacin (1 ml) was prepared in 10 ml methanol (100 ppm). 1 
ml was pipette out from 100 ppm solution and volume was made up 
with 10 ml methanol (10 ppm). The λ max was determined on UV – 
visible spectrophotometer in the range 200 – 400 nm. The λ max 
value for Nadifloxacin was found to be 237 nm. 
Selection of Mobile Phase 
The standard solution of Nadifloxacin was run and different 
combination of solvents was tried for isocratic method. The peaks 
found were well resolved and symmetric. From the various 
conditions tried, isocratic elution method using Buffer: Acetonitrile 
(70:30) was selected, since it gave sharp peaks with symmetry 
within limits and significant retention time. 
Preparation of Solutions 
Blank solutions 
Diluent was prepared using water: Acetonitrile (50:50) and pH was 
adjusted to 8.5 by using liquid ammonia. 
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Standard solutions 
10 mg Nadifloxacin was weighed accurately. Transferred into 10 ml 
volumetric flask and sufficient amount of diluent was added. Then it 
was sonicated to dissolve the drug and volume, was made up with 
diluent (1000 ppm). 1 ml of this solution was transferred to 10 ml 
volumetric flask and made up the volume with diluent (100 ppm). 
0.1 ml from 100 ppm solutions was transferred to 10 ml volumetric 
flask and made up the volume with diluent to get 1 ppm Nadifloxacin 
standard solution. 
Sample solution 
50 mg Test sample of Nadifloxacin was transferred in to 50 ml 
volumetric flask. Sufficient amount of diluent was added and 
sonicated for 2 min. Then volume was made up with diluent. 
Preparation of Mobile Phase 
Buffer Preparation: 1 ml of tri-fluro acetic acid (0.05%v/v) was 
added in 2000 ml water & sonicated. The mobile phase was 
prepared by mixing buffer & acetonitrile. 
Chromatographic Conditions 
The contents of the mobile phase were phosphate buffer solution 
(pH: 4.5) and acetonitrile in the ratio of 65:35 percent v/v. The 
mobile phase was filtered through 0.45-μm-membrane filter and 
sonicated for 15 min. The flow rate of the mobile phase was 
maintained at 1.2 ml/min. The column temperature was set at 40 
1° C and the detection was carried out by UV-Detector 
wavelength at 237 nm. The run time was set at 25 min and the 
volume of the injection loop was 5 μL. Prior to injection of the drug 
solution, the column was equilibrated for at least 30 min with the 
mobile phase flowing through the system. The data were acquired, 
stored and analyzed with the software class N-2000 CHROMTECK 
(SHIMADZU). The chromatogram obtained through the injection of 
the placebo solution did not contain any other peak at the retention 
time of Nadifloxacin. The chromatogram peak purity tools show that 
the peak was 100%. Thus, it was shown that the peak at 12.3 min 




Fig. 2: Chromatogram of placebo solution of Nadifloxacin 
 
 
Fig. 3: Chromatogram of Nadifloxacin 
 
The Liquid Chromatographic method was validated for the following 
parameters:  
Calibration procedure 
The calibration curve was plotted with five concentrations of the 
standard drug solution 0.03-10.0 ppm and chromatography was 
repeated five times for each dilution. The linearity was evaluated by 
linear regression analysis. Before injecting solutions, the column 
was equilibrated for at least 30 min with the mobile phase flowing 
through the system.  Five determinations were carried out for each 
solution, peak areas were recorded for all the solutions. The 
correlation graph was constructed by plotting the peak areas 
obtained at the optimum wavelength of detection versus the injected 
amounts of the respective concentrations. 
Linearity and range 
By using the working standard, aliquots of 0.1, 0.2, 0.3, 0.6, 1.0, 2.0, 
3.0, 4.0, 5.0, 10.0 ppm were prepared with blank solution. Five 
dilutions of each of the above mentioned concentrations were 
prepared separately and from these five dilutions, 5 μl of each 
concentration of the drug were injected into the HPLC system and 
their chromatograms were recorded. Peak areas were recorded for 
all the peaks and a standard calibration curve of peak area against 
concentration was plotted. 
Precision 
The precision of the assay was determined in terms of intra and 
inter-day variation in the peak area for a set of drug solution of 
known concentration of 80%, 100% and 120% (8 ppm, 10 ppm and 
12 ppm respectively) assayed five times on the same day and on 
three different days. The intra and inter day variation in the peak 
ratio of the drug solution was calculated in terms of co-efficient of 
variation (CV) and obtained by multiplying the ratio of standard 
deviation to the mean with 100(CV=SD/MEAN X 100). 
Robustness 
As defined by the ICH, the robustness of an analytical procedure 
describes to its capability to remain unaffected by small and 
deliberate variations in method parameters. Robustness was 
performed by small variation in the chromatographic conditions and 
found to be unaffected by small variations like ± 0.1 ml/min in flow 
rate of the mobile phase. 
Specificity and Selectivity 
The specificity of the RP-HPLC method was determined by using the 
parameters like retention time (tR) and tailing factor (Tf
Ruggedness of the developed method 
). Tailing 
factor for peaks of Nadifloxacin should be less than 2% and should 
have identical retention time. 
Ruggedness of the method was determined by running the 
developed method for Nadifloxacin analysis in two different HPLC 
systems as mentioned in the instrumentation section above. The 
results of the two different HPLC systems are compared and 
discussed in the result and discussion section below.  
RESULTS AND DISCUSSION 
The run time was set at 25 min and the retention time for 
Nadifloxacin was found 12.3 min as shown in Figure 2. The sample 
solution was injected 10 times and the retention times were found 
to be approximately same. Averages of 10 such determinations of 
peak areas are shown in Table No. 1.   
When the concentrations of Nadifloxacin and its respective peak 
areas were subjected to regression analysis by least squares method, 
a good linear relationship (r2
The proposed HPLC method was validated for intra and inter-day 
variation. When the solution containing 5, 10 and 20 μg/ml of 
Nadifloxacin was repeatedly injected on the same day, the coefficient 
of variance (CV) in the peak area for five replicate injections was 
found to be less than 0.4 %.  
 = 0.9997) was observed between the 
concentration of Nadifloxacin and the respective peak areas in the 
range 0.1 – 10.0 μg/ml. Regression of Nadifloxacin was found to be 
Y= 9.9859x -0.2301, where ‘Y’ is the peak area and ‘X’ is the 
concentration of Nadifloxacin (Fig. 4, Table No. 2). 
Also the inter day variation (3 days and five injections) was found to 
be less than 0.5% (Table No. 3). 
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Table 1: Calibration of RP- HPLC Method for Determination of 
Nadifloxacin 











*Mean of five determinations 
 
 
Fig. 4: Calibration curve of Nadifloxacin 
 
Table 2: Results of the data analysis for the quantitative 
determination of Nadifloxacin 
Statistical parameters RP-HPLC 
Concentration range, μg/ml 0.1-10.0 
Regression equation Y= 9.9859x -0.2301 
Correlation co-efficient (r2 0.9997 ) 
Limit of detection (LOQ), μg/ml 0.020 
Limit of quantification (LOD), μg/ml 0.006 
 















5 5.02 0.26 5.04 0.24 
10 10.1 0.25 10.3 0.28 
20 20.1 0.31 20.1 0.43 
 
Known amounts of the drug solution (8, 10 and 12 μg/ml) were 
subjected to the estimation of the drug for the recovery studies. 
There was a high recovery of Nadifloxacin (100.5%, 100.2%, and 
100.1%) indicating that the proposed procedure for the 
determination of Nadifloxacin is highly accurate (Table No. 4). 
The method was found to be robust as the result shows that there is 
no significance change in the result observed when there is a little 
change in the flow rate of the media. We can see that the retention 
time is almost similar when the flow rate is decreased a little bit by 
0.2 ml/min (1.0 ml/min) and when increased a little bit by 0.2 
ml/min (1.4 ml/min) (Table No. 5). 
Number of theoretical plates was found to be more than 2000 and 
the tailing factor was found to be less than 2.0 (Table No. 6). Hence 
the developed method meets the criteria of system suitability. 
When performed in two different systems (agilant and Shimadzu) 
under similar conditions, both the systems gave similar results 
(Table No. 7). Hence the ruggedness of the system is confirmed. 
Table 4: Accuracy of Lamotrigine 
Sample Percentage (%) recovery Mean 
S1-80% 99.7 100.5 
S2-80% 101.3 
S3-80% 100.4 
S1-100% 100.5 100.2 
S2-100% 101.3 
S3-100% 98.7 








Retention time (min) Tailing factor 
Flow rate (ml/min) 
1.0 10.6 0.849 
1.2 10.4 0.897 
1.4 10.4 0.982 
 
Table 6: System Suitability Parameters 
S. No. Parameters Obtained Values 
1 Theoretical plates (N) 54419 
2 Tailing factor (T) 0.897 
 
Table 7: Ruggedness of method 
 Retention time Peak Area 
Agilant 12.337 min 15.0697 
Shimadzu 12.430 min 18632 
 
CONCLUSION 
In the present investigation, we have developed a simple, sensitive, 
precise and accurate HPLC method for the quantitative estimation of 
Nadifloxacin. The results showed that the proposed method is highly 
reproducible. The HPLC method developed in the present study has 
been used to quantify Nadifloxacin in bulk. 
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